Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites ("the Company"), an international ...

TA Associates has made an undisclosed investment in UK-based Biocomposites, a maker of calcium compound biologics. Barings provided senior loans to back the transaction. No financial terms were ...

TA Associates, (Biocomposites’ majority shareholder since 2017), will reinvest in the company alongside new investor Novo Holdings and Biocomposites’ management.

As part of the transaction TA, Biocomposites' majority shareholder since 2017, will reinvest in the Company alongside new investor Novo Holdings and Biocomposites' management.

Biocomposites’ CEO Michael Harris commented: “TA has been a fantastic long-term partner to us, and we are excited for the future alongside them and Novo Holdings.” ...

Since partnering with TA in 2017, Biocomposites has achieved significant growth – including a threefold increase in revenues, successful geographic expansion, and continued product diversification.

HELLERUP, Denmark, LONDON and KEELE, England, March 3, 2025 /PRNewswire/ -- Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo ...

Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites ("the Company"), an international ...

Novo Holdings And TA Associates Partner With Biocomposites To Drive Next Chapter Of Its Growth. Date. 2025-03-03 03:45:54 ...